# Tyra Biosciences, Inc.: filings

TYRA · Nasdaq · CIK 1863127 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tyra.md) · [Financials](/companies/tyra/financials.md) · [Filings](/companies/tyra/filings.md) · [Insiders](/companies/tyra/insiders.md)

## Reports and events: 91 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 171, 144 49, 8-K 46, 3 31, 10-Q 15, SCHEDULE 13G/A 15, SC 13D/A 10, SCHEDULE 13G 9, SC 13G/A 8, CORRESP 7, DEFA14A 6, 10-K 5, DEF 14A 5, SC 13G 5, UPLOAD 5, ARS 4, EFFECT 4, SCHEDULE 13D/A 4, S-3 3, SC 13D 3, 424B5 2, S-1/A 2, S-8 2, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, D 1, DRS 1, DRS/A 1, DRSLTR 1, FWP 1, PRE 14A 1, S-1 1, S-1MEF 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-17 | 16:32 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000237.md) | Ownership report, active investor, amended | 0001346824-26-000237 |
| 2026-09-15 | 19:12 ET | [8-K](/filings/0001193125-26-390951.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-390951 |
| 2026-09-09 | 07:10 ET | [8-K](/filings/0001193125-26-385886.md) | 8.01 Other events | 0001193125-26-385886 |
| 2026-08-04 | 16:42 ET | [10-Q](/filings/0001193125-26-332995.md) | Quarterly report, period 2026-06-30 | 0001193125-26-332995 |
| 2026-08-04 | 16:04 ET | [8-K](/filings/0001193125-26-332752.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-332752 |
| 2026-06-02 | 16:01 ET | [8-K](/filings/0001193125-26-253435.md) | 5.07 Shareholder vote results | 0001193125-26-253435 |
| 2026-05-13 | 08:03 ET | [10-Q](/filings/0001193125-26-220645.md) | Quarterly report, period 2026-03-31 | 0001193125-26-220645 |
| 2026-05-13 | 08:00 ET | [8-K](/filings/0001193125-26-220638.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-220638 |
| 2026-04-17 | 08:08 ET | [DEF 14A](/filings/0001193125-26-160360.md) | Proxy statement, period 2026-05-28 | 0001193125-26-160360 |
| 2026-04-17 | 08:02 ET | [8-K](/filings/0001193125-26-160347.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-160347 |
| 2026-04-02 | 16:02 ET | [8-K](/filings/0001193125-26-140027.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-140027 |
| 2026-03-06 | 16:28 ET | [SCHEDULE 13D/A](/filings/0001346824-26-000068.md) | Ownership report, active investor, amended | 0001346824-26-000068 |
| 2026-03-04 | 17:18 ET | [8-K](/filings/0001193125-26-091880.md) | 8.01 Other events | 0001193125-26-091880 |
| 2026-03-02 | 16:27 ET | [10-K](/filings/0001193125-26-085490.md) | Annual report, period 2025-12-31 | 0001193125-26-085490 |
| 2026-03-02 | 16:09 ET | [8-K](/filings/0001193125-26-085399.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-085399 |
| 2025-12-01 | 08:00 ET | [8-K](/filings/0001193125-25-303162.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-303162 |
| 2025-11-05 | 16:14 ET | [10-Q](/filings/0001193125-25-266967.md) | Quarterly report, period 2025-09-30 | 0001193125-25-266967 |
| 2025-11-05 | 16:08 ET | [8-K](/filings/0001193125-25-266916.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266916 |
| 2025-08-22 | 21:43 ET | [8-K](/filings/0001193125-25-185553.md) | 8.01 Other events | 0001193125-25-185553 |
| 2025-08-14 | 16:17 ET | [10-Q](/filings/0000950170-25-108899.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108899 |
| 2025-08-14 | 16:11 ET | [8-K](/filings/0000950170-25-108876.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108876 |
| 2025-06-30 | 08:07 ET | [8-K](/filings/0001193125-25-152016.md) | 8.01 Other events | 0001193125-25-152016 |
| 2025-06-06 | 16:50 ET | [SCHEDULE 13D/A](/filings/0001415889-25-016006.md) | Ownership report, active investor, amended | 0001415889-25-016006 |
| 2025-05-29 | 16:22 ET | [8-K](/filings/0001193125-25-130670.md) | 5.07 Shareholder vote results | 0001193125-25-130670 |
| 2025-05-08 | 16:10 ET | [10-Q](/filings/0000950170-25-066942.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066942 |
| 2025-05-08 | 16:06 ET | [8-K](/filings/0000950170-25-066924.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066924 |
| 2025-04-18 | 15:25 ET | [DEF 14A](/filings/0001193125-25-085709.md) | Proxy statement, period 2025-05-29 | 0001193125-25-085709 |
| 2025-03-31 | 16:54 ET | [SCHEDULE 13D/A](/filings/0001415889-25-009254.md) | Ownership report, active investor, amended | 0001415889-25-009254 |
| 2025-03-27 | 16:29 ET | [10-K](/filings/0000950170-25-046124.md) | Annual report, period 2024-12-31 | 0000950170-25-046124 |
| 2025-03-27 | 16:08 ET | [8-K](/filings/0000950170-25-046064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046064 |
| 2025-01-29 | 16:05 ET | [8-K](/filings/0001193125-25-015646.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-015646 |
| 2024-12-06 | 21:30 ET | [SC 13D/A](/filings/0000895345-24-000607.md) | Ownership report, active investor, amended | 0000895345-24-000607 |
| 2024-11-19 | 21:31 ET | [SC 13D/A](/filings/0000895345-24-000595.md) | Ownership report, active investor, amended | 0000895345-24-000595 |
| 2024-11-13 | 18:04 ET | [SC 13D/A](/filings/0001104659-24-117861.md) | Ownership report, active investor, amended | 0001104659-24-117861 |
| 2024-11-07 | 16:13 ET | [10-Q](/filings/0000950170-24-123346.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123346 |
| 2024-11-07 | 16:05 ET | [8-K](/filings/0000950170-24-123286.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123286 |
| 2024-10-28 | 07:00 ET | [8-K](/filings/0001193125-24-244590.md) | 8.01 Other events | 0001193125-24-244590 |
| 2024-10-25 | 08:01 ET | [8-K](/filings/0001193125-24-243475.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-243475 |
| 2024-10-22 | 21:15 ET | [SC 13D/A](/filings/0000895345-24-000460.md) | Ownership report, active investor, amended | 0000895345-24-000460 |
| 2024-10-22 | 17:11 ET | [SC 13D/A](/filings/0001104659-24-110611.md) | Ownership report, active investor, amended | 0001104659-24-110611 |
| 2024-10-18 | 16:23 ET | [8-K](/filings/0001193125-24-239650.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-24-239650 |
| 2024-10-15 | 21:59 ET | [SC 13D/A](/filings/0000895345-24-000430.md) | Ownership report, active investor, amended | 0000895345-24-000430 |
| 2024-10-15 | 19:22 ET | [SC 13D/A](/filings/0000895345-24-000423.md) | Ownership report, active investor, amended | 0000895345-24-000423 |
| 2024-08-07 | 16:10 ET | [10-Q](/filings/0000950170-24-092778.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092778 |
| 2024-08-07 | 16:05 ET | [8-K](/filings/0000950170-24-092756.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092756 |
| 2024-05-31 | 16:02 ET | [8-K](/filings/0001193125-24-151705.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-151705 |
| 2024-05-09 | 16:12 ET | [10-Q](/filings/0000950170-24-056971.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056971 |
| 2024-05-09 | 16:08 ET | [8-K](/filings/0000950170-24-056935.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056935 |
| 2024-05-07 | 16:29 ET | [8-K](/filings/0001193125-24-133170.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-133170 |
| 2024-04-18 | 16:02 ET | [DEF 14A](/filings/0001193125-24-100755.md) | Proxy statement, period 2024-05-29 | 0001193125-24-100755 |

Page 1 of 2. [Older](/companies/tyra/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:31 ET. No prices; not investment advice.